Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$371K Buy
700
+78
+13% +$36K 0.01% 787
2026
Q1
$299K Sell
622
-30
-5% -$15.4K ﹤0.01% 812
2025
Q4
$366K Sell
652
-284
-30% -$161K 0.01% 706
2025
Q3
$481K Buy
936
+343
+58% +$150K 0.01% 604
2025
Q2
$186K Sell
593
-62
-9% -$18.6K ﹤0.01% 954
2025
Q1
$200K Buy
655
+64
+11% +$21.5K ﹤0.01% 884
2024
Q4
$196K Buy
591
+22
+4% +$7.46K ﹤0.01% 887
2024
Q3
$190K Buy
569
+10
+2% +$3.8K ﹤0.01% 893
2024
Q2
$230K Buy
559
+26
+5% +$10.3K ﹤0.01% 750
2024
Q1
$215K Sell
533
-10
-2% -$3.52K ﹤0.01% 802
2023
Q4
$166K Sell
543
-31
-5% -$8.37K ﹤0.01% 874
2023
Q3
$139K Buy
574
+8
+1% +$2.05K ﹤0.01% 886
2023
Q2
$136K Buy
566
+176
+45% +$36.6K ﹤0.01% 903
2023
Q1
$73.3K Sell
390
-24
-6% -$4.96K ﹤0.01% 1197
2022
Q4
$87.9K Buy
414
+10
+2% +$2K ﹤0.01% 1070
2022
Q3
$63K Buy
404
+37
+10% +$5.9K ﹤0.01% 1166
2022
Q2
$55K Buy
367
+103
+39% +$14.9K ﹤0.01% 1236
2022
Q1
$43K Buy
264
+219
+487% +$36.1K ﹤0.01% 1451
2021
Q4
$10K Buy
45
+27
+150% +$5.65K ﹤0.01% 2129
2021
Q3
$3K Buy
18
+2
+13% +$365 ﹤0.01% 2531
2021
Q2
$3K Buy
16
+6
+60% +$1.04K ﹤0.01% 2466
2021
Q1
$2K Buy
+10
New +$1.53K ﹤0.01% 2499
2020
Q2
Sell
-12
Closed -$1K 2598
2020
Q1
$1K Buy
+12
New +$1.04K ﹤0.01% 2140

Other funds holding MEDP

SignatureFD's MEDP Position: Q2 2026 in Review

SignatureFD increased its Medpace (MEDP) stake by 13% in Q2 2026, buying an estimated $36K and bringing the position to 700 shares worth $371K. The position accounts for 0.01% of the portfolio, ranked #787.

SignatureFD first reported a position in MEDP in Q1 2020 and has held it in 23 quarters since. The position peaked at $481K in Q3 2025. 699 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • SignatureFD held 700 shares of Medpace worth $371K as of Q2 2026.
  • SignatureFD bought 78 Medpace shares in Q2 2026, an estimated $36K.
  • Medpace made up 0.01% of SignatureFD's portfolio in Q2 2026, its #787 holding.
  • SignatureFD first reported a position in Medpace in Q1 2020 and has held it in 23 quarters since.
  • SignatureFD's Medpace position peaked at $481K in Q3 2025.
  • 699 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.